Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNeuroSense Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | -$0.12 | $0 | |||
| 09/30/2024 | Q2 2024 | -$0.05 | $0 | |||
| 03/29/2024 | Q1 2024 | -$0.35 | $0 | |||
| 04/04/2024 | Q4 2023 | -$0.19 | $0 | |||
| 09/29/2023 | Q3 2023 | $0.06 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.38 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.32 | $0 | |||
| 03/22/2023 | Q4 2022 | -$0.25 | $0 | |||
| 09/30/2022 | Q3 2022 | -$0.23 | $0 | |||
| 01/19/2023 | Q2 2022 | -$0.30 | $0 | |||
| 01/19/2023 | Q1 2022 | -$0.19 | $0 | |||
| 04/14/2022 | Q4 2021 | -$0.01 | $0 | |||
| 09/30/2021 | Q3 2021 | -$0.08 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.08 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.19 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.20 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.20 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.06 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.06 | $0 |
NeuroSense Therapeutics Ltd. Earnings: FAQ's
How can I listen to NeuroSense Therapeutics Ltd.'s earnings conference
call?
The conference call for NeuroSense Therapeutics Ltd.'s latest earnings report can be listened to online.
How can I read NeuroSense Therapeutics Ltd.'s conference call transcript?
The conference call transcript for NeuroSense Therapeutics Ltd.'s latest earnings report can be read online.
How much profit does NeuroSense Therapeutics Ltd. generate each year?
NeuroSense Therapeutics Ltd. (:NRSNW) has a recorded net income of $0. NeuroSense Therapeutics Ltd. has generated $-0.83 earnings per share over the last four quarters.
What is NeuroSense Therapeutics Ltd.'s price-to-earnings ratio?
NeuroSense Therapeutics Ltd. (:NRSNW) has a price-to-earnings ratio of -1.64 and price/earnings-to-growth ratio is 0.14.